Attorney General Scrutinizes J&J Drug Marketing

Posted on

The U.S. Attorney General last week subpoenaed Johnson & Johnson’s Ortho-McNeil Pharmaceutical division for marketing documents for epilepsy drug Topomax. J&J said it is cooperating with the AG’s Boston office.

The Raritan, NJ-based company is waiting for U.S. regulators to approve Topomax to treat migraines, Reuters reports. The Food and Drug Administration earlier this year asked Ortho-McNeil to add warnings about hypothermia and oligohidrosis (decreased sweating) to Topomax labeling, per Reuters.

More

Related Posts

Chief Marketer Videos

by Chief Marketer Staff

In our latest Marketers on Fire LinkedIn Live, Anywhere Real Estate CMO Esther-Mireya Tejeda discusses consumer targeting strategies, the evolution of the CMO role and advice for aspiring C-suite marketers.

	
        

Call for entries now open



CALL FOR ENTRIES OPEN